Status | Study |
Terminated |
Study Name: Orteronel (TAK-700) in Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors. The Greko II Study. Condition: Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors Date: 2014-03-26 Interventions: Drug: Orteronel 300mg BID |
Recruiting |
Study Name: International Ovarian & Testicular Stromal Tumor Registry Condition: Ovarian Stromal Tumor Testicular Stromal Tumors Ovarian Sm Date: 2013-10-23 |
Terminated |
Study Name: Ketoconazole as Inhibitor of the Enzyme CYP17 in Locally Advanced or Disseminated Granulosa Cell Tumour of Ovary Condition: Granulosa Cell Tumour of the Ovary Date: 2012-04-22 Interventions: Drug: Ketoconazole Patients will receive ketoconazole, 400 mg three times a day. Study treatment period |
Recruiting |
Study Name: Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors Condition: Ovarian Granulosa Cell Tumor Ovarian Gynandroblastoma Date: 2010-01-01 Interventions: Biological: Bleomycin Sulfate |
Active, not recruiting |
Study Name: Bevacizumab in Treating Patients With Recurrent Sex Cord-Stromal Tumors of the Ovary Condition: Malignant Ovarian Epithelial Tumor Ovarian Granulosa Cell Tumor Date: 2008-09-05 Interventions: Biological: Bevacizumab Given |
Completed |
Study Name: Paclitaxel in Treating Patients With Ovarian Stromal Cancer Condition: Adult Type Ovarian Granulosa Cell Tumor Ovarian Gynandroblastom Date: 2000-09-11 Interventions: Drug: Paclitaxel Given IV Other Names: |